BioInformant Worldwide, L.L.C. Market Research Reports

Title published price

Market For Cell Therapy Manufacturing - Strategies for Pricing, Cost Control, Reimbursement, Distribution, & More

By BioInformant Worldwide, L.L.C.

Executive Summary Traditionally, one of the major issues with commercializing cell therapy products has been manufacturing bottlenecks. The heterogeneous nature of cell therapy products has introduced manufacturing complex ...

04-Aug-2017 $2495

Defining the Future of the Stem Cell Industry - Exclusive Interviews with Stem Cell Industry Executives

By BioInformant Worldwide, L.L.C.

Executive Summary Stem cell research has been in process for over five decades. Stem cells have a unique ability to divide and replicate repeatedly, as well as an “unspecialized” nature that allows them to diff ...

03-Jul-2017 $1795

Stem Cell Research Products - Opportunities, Tools, and Technologies

By BioInformant Worldwide, L.L.C.

Claim this global strategic report to understand unique product opportunities by stem cell type, derive more revenue from products sold to stem cell scientists, and identify new product development opportunities before the competition. Use the &ld ...

03-Feb-2016 $3795

Mesenchymal Stem Cells - Advances & Applications

By BioInformant Worldwide, L.L.C.

Executive Summary Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and p ...

23-Nov-2015 $3795

Complete 2015-16 Global Cord Blood Banking Industry Report

By BioInformant Worldwide, L.L.C.

Executive Summary The global cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities. Serious threats to the industry include: New ...

04-Aug-2015 $3795

The Market for Stem Cell Biobanking and Storage - Size, Segments, and Trends

By BioInformant Worldwide, L.L.C.

Purpose of Report:  The purpose of this global strategic report is to prepare executives, company management, and industry investors with the data and knowledge necessary to make informed, educated decisions about commercial opportun ...

01-Jun-2015 $1395

Complete 2015-16 Induced Pluripotent Stem Cell (iPSC) Industry Report

By BioInformant Worldwide, L.L.C.

Overview Summary Recent months have seen  the first iPSC clinical trial in humans, creation of the world’s largest iPSC biobank, major funding awards, a historic challenge to the “Yamanaka Patent”, a Supreme Court ruling affecting ...

01-Apr-2015 $3795